Targeting circadian PER2 as therapy in myocardial ischemia and reperfusion injury.

作者: Tobias Eckle , Yoshimasa Oyama , Lori A Walker

DOI: 10.1080/07420528.2021.1928160

关键词:

摘要: The cycle of day and night dominates life on earth. Therefore, almost all living organisms adopted a molecular clock linked to the light-dark cycles. It is now well established that this crucial for human health wellbeing. Disruption clockwork directly results in myriad disorders, including cardiovascular diseases. Further, onset many diseases such as acute myocardial infarction exhibits circadian periodicity with worse outcomes early morning hours. Based these observations, research community became interested manipulating treat In recent years, several exciting discoveries pharmacological agents or mechanisms targeting have paved way medicine's arrival current review will outline most therapeutic advances related rhythm protein Period2 (PER2) ischemia summarize future respective field.

参考文章(109)
Borja Ibáñez, Gerd Heusch, Michel Ovize, Frans Van de Werf, Evolving therapies for myocardial ischemia/reperfusion injury. Journal of the American College of Cardiology. ,vol. 65, pp. 1454- 1471 ,(2015) , 10.1016/J.JACC.2015.02.032
Christopher M. Depner, Ellen R. Stothard, Kenneth P. Wright, Metabolic Consequences of Sleep and Circadian Disorders Current Diabetes Reports. ,vol. 14, pp. 507- 507 ,(2014) , 10.1007/S11892-014-0507-Z
Xiaoming Yang, Xuezhong He, Zhengguan Yang, Esmaiel Jabbari, Mammalian PER2 regulates AKT activation and DNA damage response. Biochemistry and Cell Biology. ,vol. 90, pp. 675- 682 ,(2012) , 10.1139/O2012-025
Stephanie Bonney, Doug Kominsky, Kelley Brodsky, Holger Eltzschig, Lori Walker, Tobias Eckle, Cardiac Per2 Functions as Novel Link between Fatty Acid Metabolism and Myocardial Inflammation during Ischemia and Reperfusion Injury of the Heart PLoS ONE. ,vol. 8, pp. e71493- ,(2013) , 10.1371/JOURNAL.PONE.0071493
J. B. Hogenesch, Y.-Z. Gu, S. Jain, C. A. Bradfield, THE BASIC-HELIX-LOOP-HELIX-PAS ORPHAN MOP3 FORMS TRANSCRIPTIONALLY ACTIVE COMPLEXES WITH CIRCADIAN AND HYPOXIA FACTORS Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 5474- 5479 ,(1998) , 10.1073/PNAS.95.10.5474
Benedetto Grimaldi, Marina Maria Bellet, Sayako Katada, Giuseppe Astarita, Jun Hirayama, Rajesh H. Amin, James G. Granneman, Daniele Piomelli, Todd Leff, Paolo Sassone-Corsi, PER2 controls lipid metabolism by direct regulation of PPARγ Cell Metabolism. ,vol. 12, pp. 509- 520 ,(2010) , 10.1016/J.CMET.2010.10.005
Holger K. Eltzschig, David S. Warner, Mark A. Warner, Adenosine: an old drug newly discovered. Anesthesiology. ,vol. 111, pp. 904- 915 ,(2009) , 10.1097/ALN.0B013E3181B060F2
Henry N. Ginsberg, Yuan-Li Zhang, Antonio Hernandez-Ono, Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes Archives of Medical Research. ,vol. 36, pp. 232- 240 ,(2005) , 10.1016/J.ARCMED.2005.01.005
R B Jennings, K A Reimer, The Cell Biology of Acute Myocardial Ischemia Annual Review of Medicine. ,vol. 42, pp. 225- 246 ,(1991) , 10.1146/ANNUREV.ME.42.020191.001301
Payaningal R Somanath, Eugene A Podrez, Juhua Chen, YI Ma, Kandice Marchant, Marina Antoch, Tatiana V Byzova, None, Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype Journal of Cellular Physiology. ,vol. 226, pp. 132- 140 ,(2011) , 10.1002/JCP.22314